BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 15845227)

  • 21. Zoonotic Escherichia coli.
    Wasteson Y
    Acta Vet Scand Suppl; 2001; 95():79-84. PubMed ID: 11995395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from cattle and sheep at slaughter.
    Tasara T; Bielaszewska M; Nitzsche S; Karch H; Zweifel C; Stephan R
    Vet Microbiol; 2008 Sep; 131(1-2):199-204. PubMed ID: 18417300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
    Karch H
    Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany.
    Kozub-Witkowski E; Krause G; Frankel G; Kramer D; Appel B; Beutin L
    J Appl Microbiol; 2008 Feb; 104(2):403-10. PubMed ID: 17887989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of enterohemorrhagic Escherichia coli O157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate.
    Wang H; Gu J; Yu S; Zhang W; Zhu Y; Zou Q; Zhu F; Mao X
    Can J Microbiol; 2010 Aug; 56(8):651-6. PubMed ID: 20725127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coil.
    Karch H; Mellmann A; Bielaszewska M
    Berl Munch Tierarztl Wochenschr; 2009; 122(11-12):417-24. PubMed ID: 19999376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Occurrence of enterohaemorrhagic E. coli (EHEC) in domestic animals].
    Bülte M
    Dtsch Tierarztl Wochenschr; 2004 Aug; 111(8):314-7. PubMed ID: 15469058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.
    Brooks JT; Sowers EG; Wells JG; Greene KD; Griffin PM; Hoekstra RM; Strockbine NA
    J Infect Dis; 2005 Oct; 192(8):1422-9. PubMed ID: 16170761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and genetic profiles of Shiga toxin-producing Escherichia coli strains isolated from buffaloes, cattle, and goats in central Vietnam.
    Vu-Khac H; Cornick NA
    Vet Microbiol; 2008 Jan; 126(4):356-63. PubMed ID: 17716835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shiga toxin-producing Escherichia coli in ground beef and lamb cuts: results of a one-year study.
    Barlow RS; Gobius KS; Desmarchelier PM
    Int J Food Microbiol; 2006 Aug; 111(1):1-5. PubMed ID: 16793157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serine protease espP subtype alpha, but not beta or gamma, of Shiga toxin-producing Escherichia coli is associated with highly pathogenic serogroups.
    Khan AB; Naim A; Orth D; Grif K; Mohsin M; Prager R; Dierich MP; Würzner R
    Int J Med Microbiol; 2009 Apr; 299(4):247-54. PubMed ID: 19036636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of enterohaemorrhagic Escherichia coli from serotype O157 and other attaching and effacing Escherichia coli on bovine carcasses in Algeria.
    Chahed A; China B; Mainil J; Daube G
    J Appl Microbiol; 2006 Aug; 101(2):361-8. PubMed ID: 16882143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterohaemorrhagic Escherichia coli in human medicine.
    Karch H; Tarr PI; Bielaszewska M
    Int J Med Microbiol; 2005 Oct; 295(6-7):405-18. PubMed ID: 16238016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli.
    Luck SN; Bennett-Wood V; Poon R; Robins-Browne RM; Hartland EL
    Infect Immun; 2005 May; 73(5):3063-71. PubMed ID: 15845514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging enterohaemorrhagic Escherichia coli, causes and effects of the rise of a human pathogen.
    Beutin L
    J Vet Med B Infect Dis Vet Public Health; 2006 Sep; 53(7):299-305. PubMed ID: 16930272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escherichia coli O157: occurrence, transmission and laboratory detection.
    Easton L
    Br J Biomed Sci; 1997 Mar; 54(1):57-64. PubMed ID: 9167308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic characteristics, virulence profile and genetic relatedness of O157 Shiga toxin-producing Escherichia coli isolated in Brazil and other Latin American countries.
    Bastos FC; Vaz TM; Irino K; Guth BE
    FEMS Microbiol Lett; 2006 Dec; 265(1):89-97. PubMed ID: 17034414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine.
    Phillips AD; Navabpour S; Hicks S; Dougan G; Wallis T; Frankel G
    Gut; 2000 Sep; 47(3):377-81. PubMed ID: 10940275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.